Emergent BioSolutions Inc. (EBS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Emergent BioSolutions Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 12.57x | -2.66x | -0.16x | -2.80x | 10.60x | 15.44x |
| P/B Ratio | 1.27x | 1.05x | 0.19x | 0.43x | 1.44x | 3.26x |
| P/S Ratio | 0.89x | 0.49x | 0.12x | 0.53x | 1.31x | 2.99x |
| Profitability | ||||||
| Gross Margin | 47.2% | 36.0% | 34.3% | 42.3% | 44.7% | 54.7% |
| Operating Margin | 14.8% | -10.4% | -69.2% | -15.2% | 19.2% | 27.8% |
| Net Margin | 7.1% | -18.3% | -72.5% | -18.9% | 12.4% | 19.4% |
| EBITDA Margin | 28.1% | 5.1% | -4.5% | 1.4% | 28.4% | 38.6% |
| Liquidity | ||||||
| Current Ratio | 5.01x | 3.69x | 1.04x | 0.98x | 3.40x | 3.11x |
| Quick Ratio | 2.41x | 1.77x | 0.54x | 0.70x | 2.47x | 2.31x |
| Leverage | ||||||
| Debt/Equity | 1.09x | 1.40x | 1.32x | 1.03x | 0.54x | 0.64x |
YoY = year-over-year change. Source: FMP..